Here is the link available on the yet to be published results for ‘The Effect of Mammalian Omega-3s on Diabetic Neuropathy‘.
Many doctors and healthcare practitioners are familiar with the complications of having diabetes. If you have diabetes or live with someone who has diabetes, you too would have or be familiar with the complications which may include neuropathy. All I can share is in my professional opinion you need not wait until the study is published to try this nutriceutical intervention. Anyone with diabetes can incorporate these Omega-3s into their daily routine .
The preliminary results were first shared at the 14th International Congress on Neuromuscular Disorders on Friday, July 8, 2016.
Let’s start this article with the early beginnings.
Over three years ago, the University of Toronto was ready to conduct a study with elite athletes regarding muscle nerve activation. One of the researchers was a member of the Canadian Sailing Team and in the past stumbled upon some difficulty in his training. With their work with athletes and hydration for the London Olympics, it was felt that something else was at the core of the difficulty.
With the research planned out, the next step was sourcing some Omega-3 supplements. Via a mutual friend, Sheldon Persad (certified coach to Olympians, etc., co-owner at Personal Best, co-founder of the Certified Professional Trainers Network (CPTN)) I was able to present the Auum mammalian Omega-3 product and its differences. I had already worked with Persad’s business partner Barrie Shepley (Canada’s National Triathlon Team coach and co-owner, Personal Best) conducting a field study using the Auum mammalian Omegas-3s with Triathletes.
Athlete Study at The University of Toronto
At the time, many researchers and doctors were not familiar with Auum mammalian Omega-3s. My role was to gage if this was a good opportunity for AUUM Canada Inc. and also (perhaps more importantly), I thought about the people (including athletes) who could potentially benefit from Auum mammalian Omegas (a naturally balanced source of Omega-6 to Omega-3 with sublingual absorption). I have a big soft spot for athletes, their passion, their discipline and drive, and more.
Click here for PubMed research on :
Diabetes Research Using Auum Mammalian Omega-3s
The University of Toronto begins putting together its research using the Auum mammalian Omega-3s and submits it to The Canadian Diabetes Association who holds an annual research competition. The well thought out research project titled ‘The Effect of Mammalian Omega-3s on Diabetic Neuropathy’ won 1st place. I was truly excited for the funding to do this research, and here are only two reasons why:
Diabetes is a leading cause of blindness in Canada. People with diabetes are more likely to develop cataracts at a younger age and are twice as likely to develop glaucoma, but diabetes’ effect on the retina is the main threat to vision. Called diabetic retinopathy, this effect of diabetes on the eyes is the most common cause of blindness in people under age 65 and the most common cause of new blindness in North America. It is estimated that approximately 2 million individuals in Canada (i.e. almost all people with diagnosed diabetes) have some form of diabetic retinopathy. – See more at: http://www.diabetes.ca/diabetes-and-you/complications/eye-damage-diabetic-retinopathy#sthash.1dKPDQ2B.dpuf
Diseases of the kidney are common in people with diabetes. In fact, up to 50% of people with diabetes demonstrate signs of kidney damage in their lifetime, but good diabetes management and regular screening can prevent or delay the loss of kidney function. http://www.diabetes.ca/diabetes-and-you/complications/kidney-disease#sthash.4EaLAXhR.dpuf
Unpublished Preliminary Results on The Effect of Mammalian Omega-3s on Diabetic Neuropathy
On Sunday, July 10, 2016 as I prepared myself with note paper and pen for the AUUM Canada Inc. meeting.
The research results were impressive but are not yet published, therefore any other information I share will have to wait for the publication.
From a holistic practitioner’s point of view, an improvement in corneal nerve fiber length sounds very GOOD indeed. From the presentation, I learned that there is currently no nutriceutical intervention for Diabetic Neuropathy – the medical focuses on two areas, insulin/glycemic management and symptom/pain management.
Mammalian Omega-3, a Choice
Everyone is unique. In my opinion, results are individual and could differ based on the various lifestyle factors, such as exercise, sleep, dietary habits, EMFs, stress factors, etc. I highly recommend that those affected with diabetes neuropathy and with the desire of trying Auum mammalian omega-3 as an intervention NEED ONLY safely consume the Omega-3 oil. In addition to lifestyle habits, the user dosage and length of time would be factors. I would recommend sublingual liquid for more effective absorption versus the capsules.
Why AUUM Mammalian Omega-3
AUUM mammalian omega-3s come from an aquatic mammalian, the harp seal. Seal oil is the other name. The processing of the oil is key as AUUM does not highly process it so essentially it is a raw and whole food supplement.
This source of omega-3 versus fish and plant omega-3 is proven to be 30% more effectively absorbed by our system. It is sublingually absorbed…but not if it is highly processed. Article on Fish Oils and Oxidization.
To purchase, press here. You may not know what neuropathy is BUT they will – pain, numbness, deformity, ulcers, gangrene, etc.
In closing, I appreciate the work of the researchers and doctors on conducting The Effect of Mammalian Omega-3s on Diabetic Neuropathy research, and to AUUM Inc. for providing the product for the research study. I look forward to the published results so I can share them with you.
One Year of Seal Oil Omega-3 Supplementation Stops the Progression of Diabetic Sensorimotor Polyneuropathy: Results from a Clinical Pilot Trial
21 days of mammalian omega-3 fatty acid supplementation improves aspects of neuromuscular function and performance in male athletes compared to olive oil placebo Evan J. H. Lewis1*, Peter W. Radonic2 , Thomas M. S. Wolever1 and Greg D. Wells2,3
Am J Clin Nutr. 1994 Dec;60(6 Suppl):1002S-1009S. Effect of triglyceride structure on fat absorption. Bracco U.
Positional Distribution of Fatty Acids in Triacylglycerols of Seal Blubber Oil Authors UDAYA N. WANASUNDARA, FEREIDOON SHAHIDI First published: March 1997 Full publication history DOI: 10.1111/j.1745-4522.1997.tb00080.x